Literature DB >> 30058386

Uterine fibroid therapy: the pharmacokinetic considerations.

Mohamed Ali1,2, Ayman Al-Hendy1.   

Abstract

Keywords:  Leiomyoma; SPRMs; liver injury; oral GnRH antagonist; pharmacokinetics; uterine fibroids

Mesh：

Substances：

Year:  2018        PMID： 30058386     DOI： 10.1080/17425255.2018.1506766

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN： 1742-5255            Impact factor:   4.481


× No keyword cloud information.
  4 in total

1.  An Evaluation of Postmarketing Reports of Serious Idiosyncratic Liver Injury Associated with Ulipristal Acetate for the Treatment of Uterine Fibroids.

Authors:  Sarah Kang; Allen Brinker; S Christopher Jones; Lara Dimick-Santos; Mark I Avigan
Journal:  Drug Saf       Date:  2020-12       Impact factor: 5.606

Review 2.  Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment.

Authors:  Qiwei Yang; Michal Ciebiera; Maria Victoria Bariani; Mohamed Ali; Hoda Elkafas; Thomas G Boyer; Ayman Al-Hendy
Journal:  Endocr Rev       Date:  2022-07-13       Impact factor: 25.261

Review 3.  Iron Deficiency Anemia in Pregnancy: Novel Approaches for an Old Problem.

Authors:  Simone Garzon; Patrizia Maria Cacciato; Camilla Certelli; Calogero Salvaggio; Maria Magliarditi; Gianluca Rizzo
Journal:  Oman Med J       Date:  2020-09-01

Review 4.  Clinical Pharmacokinetics and Pharmacodynamics of the Selective Progesterone Receptor Modulator Vilaprisan: A Comprehensive Overview.

Authors:  Marcus-Hillert Schultze-Mosgau; Bart A Ploeger; Matthias Frei; Joachim Höchel; Antje Rottmann
Journal:  Clin Pharmacokinet       Date:  2021-09-27       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.